Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Midwest Center for Metabolic and Cardiovascular Research (MCMCR) is a premier clinical research site specializing in Phase 2 through Phase 4 clinical trials for metabolic and cardiovascular disorders. Based in Louisville, Kentucky, the center is led by Medical Director Dr. Harold Bays, a renowned expert in obesity medicine and lipidology. MCMCR provides comprehensive trial execution services for pharmaceutical and biotechnology sponsors, including patient recruitment, clinical monitoring, and regulatory compliance. The facility has been instrumental in the clinical development of numerous FDA-approved therapies for conditions such as Type 2 diabetes, obesity, and dyslipidemia. With over 30 years of experience, MCMCR is recognized for its high-quality data and significant contributions to medical literature. The center operates as a dedicated research facility, ensuring focused expertise in metabolic health and cardiovascular risk reduction.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Midwest Center for Metabolic and Cardiovascular Research.